TELA Bio, Inc. (TELA) NASDAQ

Currency In USD

AD

Valuation

Market Cap55.4M
Enterprise Value60.21M
P/E Ratio-0.92
PEG Ratio-0.01
Price/Sales Ratio0.4
Price/Book Ratio-8.04
Enterprise/Revenue0.61
Enterprise/EBITDA-1.52

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.49
Operating Margin-0.42
AD

Management Effectiveness

Return On Assets-0.57
Return On Equity-13.44

Income Statement

Revenue80.28M
Revenue/Share1.41
Gross Profit54.34M
EBITDA-32.35M
Net Income-38.83M
Diluted EPS-0.83

Balance Sheet

Total Cash39.54M
Total Cash/Share0.69
Total Debt56.39M
Total Debt/Equity-10.84
Current Ratio3.61
Book Value Per Share-0.09

Price History

52-Week Change-60.55
52-Week High2.14
52-Week Low0.5
Moving Average 50 Days0.81
Moving Average 200 Days0.94

Statistics

Average Volume114,462
Shares Outstanding44.77M
% Held by Institutions46.94

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD